As of May 26
| -0.09 / -2.73%|
The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 8.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +149.22% increase from the last price of 3.21.
The current consensus among 4 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.